Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease


Journal article


G. Sathe, C. Na, S. Renuse, Anil K. Madugundu, M. Albert, A. Moghekar, A. Pandey
PROTEOMICS - Clinical Applications, 2019

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Sathe, G., Na, C., Renuse, S., Madugundu, A. K., Albert, M., Moghekar, A., & Pandey, A. (2019). Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease. PROTEOMICS - Clinical Applications.


Chicago/Turabian   Click to copy
Sathe, G., C. Na, S. Renuse, Anil K. Madugundu, M. Albert, A. Moghekar, and A. Pandey. “Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease.” PROTEOMICS - Clinical Applications (2019).


MLA   Click to copy
Sathe, G., et al. “Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease.” PROTEOMICS - Clinical Applications, 2019.


BibTeX   Click to copy

@article{g2019a,
  title = {Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease},
  year = {2019},
  journal = {PROTEOMICS - Clinical Applications},
  author = {Sathe, G. and Na, C. and Renuse, S. and Madugundu, Anil K. and Albert, M. and Moghekar, A. and Pandey, A.}
}

Abstract

The aim of this study is to identify the potential cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease and to evaluate these markers on independent CSF samples using parallel reaction monitoring (PRM) assays.